110 related articles for article (PubMed ID: 631030)
1. [Long-term treatment of cerebrovascular changes in the elderly (author's transl)].
Kugler J; Oswald WD; Herzfeld U; Seus R; Pingel J; Welzel D
Dtsch Med Wochenschr; 1978 Mar; 103(11):456-62. PubMed ID: 631030
[TBL] [Abstract][Full Text] [Related]
2. Hydergine: a review of 26 clinical studies.
McDonald RJ
Pharmakopsychiatr Neuropsychopharmakol; 1979 Nov; 12(6):407-22. PubMed ID: 538085
[TBL] [Abstract][Full Text] [Related]
3. [Treatment of organic brain psychosyndrom in the old age. A double blind study with Hydergin (author's transl)].
Biel ML; Seus R; Struppler A
Med Klin; 1976 Dec; 71(49):2177-84. PubMed ID: 794665
[TBL] [Abstract][Full Text] [Related]
4. [Bencyclan (Fludilat) in the treatment of patients with ischaemic cerebral infarction (author's transl)].
Schneider E; Fischer PA; Jacobi P
Med Klin; 1976 Sep; 71(39):1611-6. PubMed ID: 790129
[TBL] [Abstract][Full Text] [Related]
5. [Eutergin in the treatment of chronic cerebrovascular disturbance patterns (author's transl)].
Prosenz P
Aktuelle Gerontol; 1980 Jun; 10(6):245-51. PubMed ID: 6109460
[TBL] [Abstract][Full Text] [Related]
6. An ergot alkaloid preparation (Hydergine) in the treatment of dementia: critical review of the clinical literature.
Hughes JR; Williams JG; Currier RD
J Am Geriatr Soc; 1976 Nov; 24(11):490-7. PubMed ID: 823192
[TBL] [Abstract][Full Text] [Related]
7. [Clinical, psychological and neurophysiological results of double-blind study on vincamine-cromesilate in patients with cerebro-vascular insufficiency (author's transl)].
Mikus P
Arzneimittelforschung; 1978; 28(11):2165-8. PubMed ID: 582924
[TBL] [Abstract][Full Text] [Related]
8. Double-blind placebo-controlled study with citicoline in APOE genotyped Alzheimer's disease patients. Effects on cognitive performance, brain bioelectrical activity and cerebral perfusion.
Alvarez XA; Mouzo R; Pichel V; Pérez P; Laredo M; Fernández-Novoa L; Corzo L; Zas R; Alcaraz M; Secades JJ; Lozano R; Cacabelos R
Methods Find Exp Clin Pharmacol; 1999 Nov; 21(9):633-44. PubMed ID: 10669911
[TBL] [Abstract][Full Text] [Related]
9. Naftidrofuryl in the treatment of mild senile dementia. A double-blind study.
Grossmann WM; Standl A; May U; van Laak HH; Hirche H
Pharmacopsychiatry; 1990 Nov; 23(6):265-73. PubMed ID: 2284328
[TBL] [Abstract][Full Text] [Related]
10. [Psychological studies of a long-term treatment of the neurovascular syndrom with Trivastal (author's tranls)].
Scholing WE; Clausen HD
Med Klin; 1975 Sep; 70(38):1522-7. PubMed ID: 1102887
[TBL] [Abstract][Full Text] [Related]
11. [Hydergin therapy of cerebrovascular insufficiency in patients requiring digitalis. Results of a double-blind study (author's transl)].
Dennler HJ; Bachmann H
MMW Munch Med Wochenschr; 1979 Nov; 121(48):1615-8. PubMed ID: 118360
[TBL] [Abstract][Full Text] [Related]
12. Double-blind, randomized, placebo-controlled pilot study with anapsos in senile dementia: effects on cognition, brain bioelectrical activity and cerebral hemodynamics.
Alvarez XA; Pichel V; Pérez P; Laredo M; Corzo D; Zas R; Fernández-Novoa L; Sempere JM; Díaz J; Cacabelos R
Methods Find Exp Clin Pharmacol; 2000 Sep; 22(7):585-94. PubMed ID: 11196347
[TBL] [Abstract][Full Text] [Related]
13. [Letter: Double blind study of hydergine in aged patients].
Paux G; Boismare F; Delaunay P
Nouv Presse Med; 1975 Oct; 4(35):2529. PubMed ID: 812060
[No Abstract] [Full Text] [Related]
14. [Analytic study on EEG features of aging with/without psychiatric disorders: focussing at the alterations in the EEGs of the healthy, depressive and demented elderlies].
Saito N
Seishin Shinkeigaku Zasshi; 1995; 97(10):801-24. PubMed ID: 8552725
[TBL] [Abstract][Full Text] [Related]
15. [Controlled double-blind study of the clinical equivalent of two posologic regimens of Hydergine: 1 x 4,5mg compared to 3 x 1,5mg per day].
Piguet PV; Zoufal Z
Rev Med Suisse Romande; 1981 Feb; 101(2):157-63. PubMed ID: 7015453
[No Abstract] [Full Text] [Related]
16. [On the role of vincamine in the therapy of cerebrovascular diseases and impairment of cerebral function (author's transl)].
Witzmann HK; Blechacz W
Arzneimittelforschung; 1977; 27(6a):1238-47. PubMed ID: 332190
[No Abstract] [Full Text] [Related]
17. Dihydroergocryptine in the management of senile psycho-organic syndrome.
Scarzella L; Bono G; Bergamasco B
Int J Clin Pharmacol Res; 1992; 12(1):37-46. PubMed ID: 1526697
[TBL] [Abstract][Full Text] [Related]
18. [Treatment of cerebral vascular insufficiency syndromes in old age. Controlled research by double blind technic].
Mars G; Nebuloni G
G Gerontol; 1970 Mar; 18(3):153-76. PubMed ID: 4919664
[No Abstract] [Full Text] [Related]
19. [Clinico-rheographic study of the cerebrovascular effect of alpha-adrenergic blockers in vascular diseases of the brain].
Shtok VN; Varlamova IV; Fedorova NV; Timurbaator
Zh Nevropatol Psikhiatr Im S S Korsakova; 1985; 85(9):1333-8. PubMed ID: 4072531
[TBL] [Abstract][Full Text] [Related]
20. Double-blind clinical and psychologic study of ergoloid mesylates (Hydergine) in subjects with senile mental deterioration.
van Loveren-Huyben CM; Engelaar HF; Hermans MB; van der Bom JA; Leering C; Munnichs JM
J Am Geriatr Soc; 1984 Aug; 32(8):584-8. PubMed ID: 6379022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
